Evidence map›Paper›PMID 28772241›Full record

ArticleNeoplasia (New York, N.Y.)2017

NF-κB p65 Overexpression Promotes Bladder Cancer Cell Migration via FBW7-Mediated Degradation of RhoGDIα Protein.

Junlan Zhu, Yang Li, Caiyi Chen, Jiugao Ma, Wenrui Sun, Zhongxian Tian, Jingxia Li, Jiheng Xu, Claire S Liu, Dongyun Zhang and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Nuclear Factor-κB Clinical Significance in Breast Cancer: An Immunohistochemical Study.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Junlan ZhuSchool of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang, China 325035; Nelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY 10987, USA.
Yang LiSchool of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang, China 325035; Nelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY 10987, USA.
Caiyi ChenSchool of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang, China 325035.
Jiugao MaSchool of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang, China 325035.
Wenrui SunSchool of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang, China 325035.
Zhongxian TianSchool of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang, China 325035; Nelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY 10987, USA.
Jingxia LiNelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY 10987, USA.
Jiheng XuSchool of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang, China 325035; Nelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY 10987, USA.
Claire S LiuNelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY 10987, USA.
Dongyun ZhangNelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY 10987, USA.
Chuanshu HuangSchool of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang, China 325035; Nelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY 10987, USA. Electronic address: Chuanshu.huang@nyumc.org.
Haishan HuangSchool of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang, China 325035. Electronic address: haishan_333@163.com.
Wenzhou Medical University · CNNew York University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince invasive bladder cancer (BC) is one of the most lethal urological malignant tumors worldwide, understanding the molecular mechanisms that trigger the migration, invasion, and metastasis of BC has great significance in reducing the mortality of this disease. Although RelA/p65, a member of the NF-kappa B transcription factor family, has been reported to be upregulated in human BCs, its regulation of BC motility and mechanisms have not been explored yet.

methodsNF-κBp65 expression was evaluated in N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN)-induced high invasive BCs by immunohistochemistry staining and in human BC cell lines demonstrated by Western Blot. The effects of NF-κBp65 knockdown on BC cell migration and invasion, as well as its regulated RhoGDIα and FBW7, were also evaluated in T24T cells by using loss- and gain-function approaches. Moreover, the interaction of FBW7 with RhoGDIα was determined with immunoprecipitation assay, while critical role of ubiquitination of RhoGDIα by FBW7 was also demonstrated in the studies.

resultsp65 protein was remarkably upregulated in the BBN-induced high invasive BCs and in human BC cell lines. We also observed that p65 overexpression promoted BC cell migration by inhibiting RhoGDIα expression. The regulatory effect of p65 on RhoGDIα expression is mediated by its upregulation of FBW7, which specifically interacted with RhoGDIα and promoted RhoGDIα ubiquitination and degradation. Mechanistic studies revealed that p65 stabilizing the E3 ligase FBW7 protein was mediated by its attenuating pten mRNA transcription.

conclusionsWe demonstrate that p65 overexpression inhibits pten mRNA transcription, which stabilizes the protein expression of ubiquitin E3 ligase FBW7, in turn increasing the ubiquitination and degradation of RhoGDIα protein and finally promoting human BC migration. The novel identification of p65/PTEN/FBW7/RhoGDIα axis provides a significant insight into understanding the nature of BC migration, further offering a new theoretical support for cancer therapy.

Indexed as

Gene ExpressionAnimalsCell Line, TumorCell MovementDisease Models, AnimalF-Box-WD Repeat-Containing Protein 7Genes, ReporterHeterograftsHumansMiceMice, KnockoutProtein BindingProtein Stabilityrho Guanine Nucleotide Dissociation Inhibitor alphaTranscription Factor RelAUrinary Bladder NeoplasmsF-Box-WD Repeat-Containing Protein 7FBXW7 protein, humanrho Guanine Nucleotide Dissociation Inhibitor alphaTranscription Factor RelA

Identifiers

PMID28772241
PMCPMC5540704
OpenAlexW2739778285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.